注册并分享邀请链接,可获得视频播放与邀请奖励。

CSRxP
@RxPricing
CSRxP fosters a national dialogue focused on the pricing of new high-cost drug therapies and striking a balance between innovation and affordability.
加入 June 2014
976 正在关注    3.4K 粉丝
Despite the savings greater biosimilar competition can deliver, Big Pharma continues to game the system to block more affordable alternatives from reaching patients. Lawmakers should build on recent bipartisan work to advance bipartisan, market-based solutions. More from @Axios:
显示更多